Emcure Pharmaceuticals Ltd., a leading Indian pharmaceutical company, and its subsidiary, Gennova Biopharmaceuticals Limited, have signed a 22.78 MWp DC Solar Power Purchase Agreement (PPA) with Sunsure Energy, a major renewable power producer in India. This partnership will provide Emcure and Gennova with approximately 36 million kWh of clean energy annually for their Pune plants. According to Emcure, this deal will fulfill around 67% of their power needs with green energy and reduce CO2 emissions by 29,765.71 metric tons per year. As part of the PPA, Emcure and Gennova will acquire a stake in Sunsure Solarpark Twelve Private Limited, under a group captive scheme in accordance with the Electricity Act, 2023. Sunsure will supply the power from its 150 MWp DC solar plant in Solapur, Maharashtra.
Emcure signs 22.78 MWp solar power agreement
Emcure and Gennova will acquire a stake in Sunsure Solarpark Twelve Private Limited as part of the agreement. (Image Credit: Pixabay)
The dual-use project integrates agriculture under solar panels and floating aquaculture with energy storage. (Image Source: PRNewswire)
The Horsham project combines solar and battery storage, supporting grid stability and peak demand management. (Image Credit/Source: Atimedia/Pixabay)
The 20 MW solar project actively supports Eramet’s SBTi roadmap and climate goals. (Image Source: SolarPanal/Pixabay)
Sherco Solar is the Upper Midwest’s largest solar project, set to power 150,000 homes when fully operational. (Image Source: Xcel Energy)